Dr Ni Ni Tun
Ni Ni Tun
Medical and research advisor
Ni Ni is working as HIV innovative and research advisor for Medical Action Myanmar and Myanmar Oxford Clinical Research Unit. Currently, she is also PhD Fellow student at the University of Antwerp, Belgium with the research areas of relevant interventions to tackle the gaps in HIV prevention and treatment care in Key Affected Populations (KAPs), Myanmar.
- Demonstration of engagement and treatment outcomes of HIV, TB and PMTCT patients
- a cross-sectional study on the prevalence of chlamydia or gonorrhoea diagnosed using a point of care nucleic acid amplification test (Xpert® CT/NG) among female sex workers attending the MAM satellite.
- Perception, acceptability of Pre-exposure prophylaxis of HIV infection among men who have sex with men and transgender in Suburban Yangon, Myanmar (mixed-method)
- Treatment failure in HIV-positive children in Myanmar
- Outpatient opioid substitution therapy integrated with HIV/HCV care in low-and middle-income countries: A systematic review.
- HIV test uptake and cascade of care among people with intravenous drug users in Myanmar
- HIV viral load uptake and utilization after rapid decentralized testing with GeneXpert in Urban area, Myanmar
- Specialized HCV care for people who inject drugs in remote Myanmar with tele-mentoring of general practitioners and peer-led community support
Institutional affiliation(s); Medical action Myanmar and Myanmar Oxford Clinical Research Unit
City and country of primary residence; Yangon, Myanmar
Near point-of-care HIV viral load testing: Cascade after high viral load in suburban Yangon, Myanmar.
Tun NN. et al, (2023), PLoS One, 18
Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar
Warrell CE. et al, (2021), BMC Infectious Diseases, 21
Caring for Hospitalized COVID-19 Patients: From Hypes and Hopes to Doing the Simple Things First.
Schultz MJ. et al, (2021), The American journal of tropical medicine and hygiene
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial
McLean ARD. et al, (2021), The Lancet Infectious Diseases, 21, 1579 - 1589
Observational study of adult respiratory infections in primary care clinics in Myanmar: understanding the burden of melioidosis, tuberculosis and other infections not covered by empirical treatment regimes
Warrell CE. et al, (2021), Transactions of The Royal Society of Tropical Medicine and Hygiene, 115, 914 - 921